BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Participate in Breakthrough for Brain Tumors(R) 5K Run
Oct 10, 2022
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run. The event is taking place on Saturday, Nov. 5, 2022, in Los Angeles, California. “The unmet need in brain tumor treatment is immense and knows no geographic borders. As CEO of CNS, I have come to know many brain tumor patients personally and the optimism and strength with which they have all faced this terrible diagnosis is a continuing source of inspiration to me. Supporting these patients, their journey and the challenges they currently endure is not just a priority for us, it is why we do what we do,” Climaco said. “Across the globe there is an urgent need for safe and effective GBM treatment options, and I am proud to participate in the BT5K to support the mission of the ABTA, to help bring hope to patients and families and to raise much needed funds for research.”
To view the full press release, visit https://ibn.fm/e1CPq
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Additionally, the company is advancing the development of its WP1244 drug technology portfolio, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500x more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of the WP1244 portfolio in the treatment of brain cancers, pancreatic, ovarian, and lymphomas. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Asian Games 2026 Highlights: Shooters Add 3 Medals, Shuttlers And Paddlers Enter Quarters
India in Asian Games Highlights: It was another good day for the Indian contingent.
'Why Was I Alone?': Varun Sanyal, Son Of PM Advisory Council Member, After Controversial Asiad Exit
Indian MMA fighter Varun Sanyal, on of Prime Minister Narendra Modi's Economic Advisory Council member, has questioned why was he left alone at his weight cut.
Asian Games 2026: India Shooters Continue To Shine, Suchika Clinches Historic Bronze
Shooters were the star for India on Tuesday as they added as many as three medals to the country's tally.
Nearly half of Taiwanese lack confidence in US defence commitments, survey finds
Nearly half of Taiwanese lack confidence that Washington will continue military aid and arms sales to the island, a new survey shows. The results of the poll were released on Monday, ahead of this week’s summit between US President Donald Trump and Chinese leader Xi Jinping. The poll by Taiwan-based United Daily News found 47 per cent were not confident the United States would continue providing military assistance and selling weapons to Taiwan, slightly exceeding the 44 per cent who remained...
Railway works worth over ₹20,000 crore under way in Kerala, says Vaishnaw
Mangaluru to stay in SWR zone; land acquisition lag holding up several sanctioned lines and doubling projects
China allows foreign visitors to skip police stations, register stay online
Foreign visitors to China who choose to stay somewhere other than a hotel can now register their accommodation with the authorities online, which analysts say will make travelling to the country more convenient. China’s Exit and Entry Administration Law mandates that foreigners register their accommodation with the police within 24 hours of arrival. Those who fail to do so could be issued a warning or fined up to 2,000 yuan (US$298). This applies both to foreign visitors arriving in the country...
Shooter Rudrankksh Patil Questions Why He Hasn't Won Arjuna Award: 'It Is Very Funny'
Indian shooter Rudrankksh Patil questions why he hasn't received the Arjuna Award despite being a world champion and applying for three years.
Former Shenzhen mayor Qin Weizhong under corruption probe by China’s discipline watchdog
Qin Weizhong, former mayor of the southern technology hub of Shenzhen, is under investigation for corruption, the country’s top watchdog has confirmed. According to a statement by the Central Commission for Discipline Inspection on Monday, Qin is “suspected of grave disciplinary and law violations and is currently undergoing review”, which usually means a corruption probe. Qin was appointed deputy party secretary and mayor of Shenzhen in May 2021. On August 24 this year, those positions were...
Thiruvananthapuram's 'Emerald Island': A 167-year-old zoo caught in relocation debate
Chief Minister V D Satheesan recently suggested moving the zoo to Neyyar or another forest area, saying wild animals should be kept closer to their natural habitat
Budhiganga River erosion threatens settlements, farmland in far west
Key Takeaways: River erosion is destroying farmland in Bajura and Achham, with productive fields turning into riverbeds Dozens of settlements are at risk, and some families have...
China’s Djibouti base upgrade may give PLA eyes on foreign military in Middle East
China has upgraded its military base in Djibouti with communications equipment a US think tank says is “likely enhancing” the country’s ability to collect signals intelligence – potentially giving the PLA a window on foreign military operations in Djibouti and the wider Middle East. The Chinese facility sits within 16km (10 miles) of US, French, Italian and Japanese military bases, according to the Centre for Strategic and International Studies (CSIS), in an unusually concentrated environment in...
IIT Bombay says its director hasn't quit, apologises for earlier communication on student's death
The student’s family alleges that Wakode, a native of Maharashtra's Yavatmal district, was subjected to institutional harassment and caste-based discrimination before he took the extreme step
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.